Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.

作者信息

Godfrey Catherine, Thigpen Michael C, Crawford Keith W, Jean-Phillippe Patrick, Pillay Deenan, Persaud Deborah, Kuritzkes Daniel R, Wainberg Mark, Raizes Elliot, Fitzgibbon Joseph

机构信息

National Institute of Allergy and Infectious Diseases, National Institutes of Health.

University College London, United Kingdom.

出版信息

J Infect Dis. 2017 Dec 1;216(suppl_9):S798-S800. doi: 10.1093/infdis/jix137.

DOI:10.1093/infdis/jix137

PMID:28973412

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853929/

Abstract

摘要

相似文献

[1]

Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.

J Infect Dis. 2017-12-1

[2]

HIV resistance and the developing world.

Int J Antimicrob Agents. 2007-5

[3]

The Impact of HIV-1 Drug Escape on the Global Treatment Landscape.

Cell Host Microbe. 2019-7-10

[4]

Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.

Clin Infect Dis. 2009-5-1

[5]

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.

J Infect Dis. 2004-7-15

[6]

Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.

AIDS. 2016-4-24

[7]

Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.

PLoS One. 2015-10-29

[8]

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.

PLoS One. 2017-6-5

[9]

Antiretroviral update: recent advances expand options for patients with HIV.

Adv Nurse Pract. 2004-11

[10]

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Clin Infect Dis. 2016-7-1

引用本文的文献

[1]

HIV-1 subtype distribution and drug resistance profiles among PLWHA with detectable viremia in Henan Province, China, 2023.

Sci Rep. 2025-5-22

[2]

In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae.

Mar Drugs. 2024-7-31

[3]

Strengthening and enhancing national antiretroviral drug resistance surveillance in Zimbabwe-A country that has reached UNAIDS 95-95-95 amongst adults.

Front Public Health. 2024-2-14

[4]

"I can live a normal life": Exploring adherence to antiretroviral therapy in Indonesian adolescents living with HIV.

Belitung Nurs J. 2022-4-26

[5]

Achieving virological control in pan-resistant HIV-1 infection: A case series.

EBioMedicine. 2022-3

[6]

First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia.

Afr Health Sci. 2021-3

[7]

Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site mutations of highly drug resistant mutant PR.

Biochem Biophys Res Commun. 2021-8-20

[8]

HIV Drug Resistance in Children and Adolescents: Always a Challenge?

Curr Epidemiol Rep. 2021

[9]

HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017.

Transfus Med. 2021-4

[10]

Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication.

Sci Rep. 2020-8-6

本文引用的文献

[1]

Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring.

Lancet Infect Dis. 2017-1

[2]

Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

Virol J. 2016-10-12

[3]

SHIVA - a web application for drug resistance and tropism testing in HIV.

BMC Bioinformatics. 2016-8-22

[4]

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact.

PLoS One. 2016-7-8

[5]

Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study.

Lancet HIV. 2016-4-7

[6]

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.

Antimicrob Agents Chemother. 2016-5-23

[7]

High Prevalence of HIV Low Abundance Drug-Resistant Variants in a Treatment-Naive Population in North Rift Kenya.

AIDS Res Hum Retroviruses. 2015-12

[8]

A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK.

AIDS. 2015-9-24

[9]

Minority drug-resistant HIV-1 variants in treatment naïve East-African and Caucasian patients detected by allele-specific real-time PCR.

PLoS One. 2014-10-21

[10]

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

N Engl J Med. 2014-7-17

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献